SECURITY AGREEMENT
(Patent)
THIS SECURITY AGREEMENT (PATENT)
(“ Agreement ”),
is entered into and made effective as of August 8, 2008, by and
between IR BIOSCIENCES HOLDINGS, INC., a Delaware
corporation with its principal place of business located at 8767 E.
Via De Ventura, Suite 190, Scottsdale, AZ 85258 (the “
Parent ”), and the each subsidiary of the Parent
listed on Schedule I attached hereto (each a “
Subsidiary ,” and collectively and together with the
Parent, the “ Company ”), in favor of Brencourt
Advisors, LLC as agent (the “ Secured Party ”)
for the holders of the Convertible Debentures referred to in the
following paragraph (the “ Holders
”).
WITNESETH:
WHEREAS, in connection with the Securities Purchase
Agreement by and among the Parent and the Secured Party of even
date herewith (the “ Securities Purchase
Agreement ”), the Parent has agreed, upon the terms and
subject to the conditions of the Securities Purchase Agreement, to
issue to the Holders (i) an aggregate original principal amount of
up to $5,000,000 of senior secured convertible debentures (the
“ Convertible Debentures ”), which shall be
convertible into shares of the Parent’s Common Stock (the
“ Conversion Shares ”); and (ii) warrants (the
“ Warrants ”) to be exercisable to acquire
additional shares of Common Stock (the “ Warrants
Shares ”) initially in that number of shares of Common
Stock set forth in the Securities Purchase Agreement;
WHEREAS, to induce each Holder to purchase the
Convertible Debentures and enter into the Securities Purchase
Agreement and the documents entered into in connection therewith,
(collectively referred to as the “ Transaction
Documents ”), each Company hereby grants to the Secured
Party a security interest, in and to the Patent Collateral (as
defined below) to secure all of the Obligations (as defined
below).
WHEREAS , in connection with the Securities Purchase
Agreement, each Company has agreed to provide the Secured Party a
general security interest in the Pledged Property (as this term is
defined in the Security Agreement by and between each Company and
the Secured Party, dated August 8, 2008 (together with all
amendments, supplements, restatements and other modifications, if
any, from time to time made thereto, the “ Security
Agreement ”);
WHEREAS , each Company has duly authorized the
execution, delivery and performance of this Agreement;
NOW THEREFORE
, for good and valuable
consideration, the receipt of which is hereby acknowledged, the
Company agrees as follows:
SECTION 1.
Definitions. Unless otherwise defined herein
otherwise requires, terms used in this Agreement, including its
preamble and recitals, have the meanings provided in the Securities
Purchase Agreement.
(a) “
Obligations ” shall have the meaning assigned to it in
the Security Agreement.
SECTION 2. Grant of
Security Interest. For good and valuable
consideration, the receipt and sufficiency of which are hereby
acknowledged, to secure the payment and performance of all of the
Obligations of the Company, the Company does hereby mortgage,
pledge and hypothecate to the Secured Party and grant to the
Secured Party a security interest in all of the following property
(the “ Patent Collateral ”), now owned and
existing:
(a) all letters patent
and applications for letters patent throughout the world, including
all patent applications in preparation for filing anywhere in the
world and including each patent and patent application referred to
in Schedule A hereto;
(b) all reissues,
divisions, continuations, continuations-in-part, extensions,
renewals and reexaminations of any of the items described in clause
(a);
(c) all patent
licenses and other agreements providing the Company with the right
to use any of the items of the type referred to in clauses (a) and
(b), including each patent license referred to in Schedule A
hereto;
(d) the right to sue
third parties for past, present or future infringements of any
Patent Collateral described in clauses (a) and (b) and, to the
extent applicable, clause (c); and
(e) all proceeds of,
and rights associated with, the foregoing, (including license
royalties and proceeds of infringement suits), and all rights
corresponding thereto throughout the world.
SECTION 3. Security
Agreement . This Agreement has been executed and
delivered by each Company for the purpose of recording the security
interest of the Secured Party in the Patent Collateral relating to
patents referred to in Schedule A with the United States
Patent and Trade Marks Office, to the extent it may be so
registered therein. The security interest granted hereby
has been granted as a supplement to, and not in limitation of, the
security interest granted to the Secured Party under the Security
Agreement. The Security Agreement (and all rights and
remedies of the Secured Party thereunder) shall remain in full
force and effect in accordance with its terms.
SECTION 4. Release of
Security Interest. Upon payment in full of all
Obligations the Secured Party shall, at the Company’s
expense, execute and deliver to the Company all instruments and
other documents as may be necessary or proper to release the lien
on any security interest in the Patent Collateral which has been
granted hereunder.
SECTION 5.
Acknowledgement. The Company does hereby further
acknowledge and affirm that the rights and remedies of the Secured
Party with respect to the security interest in the Patent
Collateral granted hereby are more fully set forth in the Security
Agreement, the terms and provisions of which (including the
remedies provided for therein) are incorporated by references
herein as if fully set forth herein.
SECTION 6. Securities
Purchase Agreement . Notwithstanding any other term
or provision hereof, in the event that any provisions hereof
contradict and are incapable of being construed in conjunction with
the provisions of the Securities Purchase Agreement, the provisions
of the Securities Purchase Agreement shall take precedence over
those contained herein and, in particular, if any act of the
Company is expressly permitted under the Securities Purchase
Agreement but is prohibited hereunder, any such act shall be
permitted hereunder and any encumbrance expressly permitted under
the Securities Purchase Agreement to exist or to remain outstanding
shall be permitted hereunder and thereunder. This instrument,
document or agreement may be sold, assigned or transferred by the
Agent in accordance with the terms of the Securities Purchase
Agreement.
SECTION 7.
Counterparts. This Agr